Geriatric Medicine

The American Association of Diabetes Educators released a new position statement to help guide diabetes educators on how to help older adults with diabetes.  The position paper, “Special Considerations in the Management and Education of Older Persons with Diabetes,” is now available.

All older people should routinely take antihypertensives to prevent cardiovascular disease and stroke, even if they don’t have high blood pressure, according to British researchers.

Numerous lifestyle factors affect older adults’ risk of diabetes, a new study finds. As the population ages, even small changes affect incidence, study finds.

Having hypoglycemic (low blood sugar level) episodes that are severe enough to require hospitalization are associated with a greater risk of dementia for older adults with Type 2 diabetes, according to a study.

In a new report, researchers from Mount Sinai School of Medicine have found a gene that may be involved in the link between Type 2 diabetes and Alzheimer’s disease. Previous research has found that healthy elderly people with Type 2 diabetes are twice as likely to develop Alzheimer’s disease, but …

The presence of a protein expressed by the liver which inhibits insulin action may identify individuals more likely to develop type 2 diabetes, according to a new study. This is a protein you will be hearing more about.

Adults with type 2 diabetes who eat high-fat meals may experience memory declines immediately afterward, but this can be offset by taking antioxidant vitamins with the meal, according to new research.

A Modified MyPyramid for Older Adults has been developed to serve older adults, who have unique dietary needs and less familiarity with computer use vs younger persons.

Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study.

Angiotensin-converting enzyme inhibitors that cross the blood-brain barrier slow mental decline by about 50% relative to the decline seen in patients on other antihypertensives, according to an observational study of 1,074 hypertensive subjects followed for a median of 6 years.